Digital Diabetes Management Market Analysis and Forecast 2024-2028

The Global digital diabetes management market is projected to grow by USD 19.12 billion at a CAGR of 21.99% between 2023 and 2028. The market encompasses technological tools such as wearables, smartphone applications, and cloud-based platforms designed to monitor and manage diabetes effectively. The increasing global prevalence of diabetes has fueled the demand for digital solutions that improve patient adherence, enhance outcomes, and reduce healthcare costs

For more details about the industry, get the PDF sample report for free

Market Segmentation

End-User Outlook

Hospitals

The hospitals segment will experience significant growth. Hospitals integrate mobile applications, online platforms, electronic health records (EHRs), medical devices, and telehealth services to enhance diabetes care.

Key aspects of this segment include:

• Remote patient monitoring
• Diabetes education and self-management
• Electronic health records (EHRs)
• Telehealth services
• Medical device integration
• Data analytics and decision support

The hospitals segment was valued at USD 1.77 billion in 2018. The adoption of digital tools in hospitals is expected to drive market growth by providing personalized care, improved healthcare access, and better patient participation.

Home Settings

The home settings segment includes digital diabetes management solutions designed for personal use. These tools allow patients to monitor their blood glucose levels, physical activity, and medication adherence from home, reducing the need for frequent hospital visits.

Diagnostic Centers

Diagnostic centers employ wearable devices, glucose monitoring systems, and AI-based analytics to provide early detection and continuous monitoring of diabetes. The integration of cloud-based software helps improve data analysis, patient tracking, and treatment optimization.

Type Outlook

Wearable Devices

Wearable devices play a crucial role in diabetes management by offering continuous glucose monitoring (CGM) and insulin delivery systems. This segment includes:

• CGM systems
• Insulin pumps
• Wearable insulin patches
• Smartwatches and fitness trackers with glucose monitoring features

These devices were initially developed for type 1 diabetes but have expanded to type 2 diabetes patients due to technological advancements. The segment is further driven by regulatory approvals for CGM systems, the development of closed-loop pump systems, and smart insulin patches.

Hand-Held Devices

Hand-held devices provide portable solutions for blood glucose monitoring and insulin administration. These include:

• Smart insulin pens
• Blood glucose meters
• Digital insulin pumps
• Hand-held continuous glucose monitors

The integration of AI-driven data analytics and smartphone applications with these devices enhances their usability and effectiveness in managing diabetes.

Regional Market Trends

North America

North America is projected to contribute 46% of the global market growth. The region's demand for telemedicine platforms and remote patient monitoring devices is increasing due to the rising prevalence of diabetes.

Key growth factors:

• High adoption of digital health technologies
• Favorable government initiatives and regulatory support
• Strong presence of key market players, including Medtronic, Dexcom, Abbott Laboratories, Insulet Corporation, and Livongo Health

Regional Breakdown

• North America

  • The U.S.
  • Canada

• Europe

  • The U.K.
  • Germany
  • France
  • Rest of Europe

• Asia

  • China
  • India
  • Rest of Asia

• Rest of the World (ROW)

  • Argentina
  • Australia
  • Brazil

Market Dynamics

Key Market Drivers

The rising global burden of diabetes is a primary market driver. The number of diabetes cases is expected to double over the next 25 years.

Factors fueling growth:

• Increased urbanization and obesity rates in high-population countries such as China and India
• Growing demand for digital diabetes management systems
• Need for cost-effective diabetes monitoring and treatment solutions

As a result, demand for advanced digital diabetes management solutions is expected to rise significantly.

Significant Market Trends

The increasing adoption of wearable devices is shaping market growth. These devices allow users to track blood sugar levels, physical activity, and overall health in real time.

Key advancements:

• Built-in insulin pumps
• Continuous glucose monitoring (CGM)
• Smartphone and cloud platform connectivity

Wearable technology promotes self-management, continuous monitoring, and personalized treatment plans, leading to better patient health outcomes and quality of life.

Major Market Challenges

The stringent regulatory framework poses challenges for market players. Digital diabetes management devices, including smart insulin pumps and infusion sets, are classified as Class II medical devices by the U.S. FDA.

Challenges include:

• Strict regulatory approvals before market entry
• Risk of product recalls due to non-compliance
• Post-market approval requirements delaying product launches

Companies must navigate these regulatory barriers while ensuring product safety and innovation.

Get more details by ordering the complete report

Key Market Players

Companies are adopting alliances, mergers, acquisitions, and product launches to expand their market presence. The following 20 key companies play a significant role in the market:

• Abbott Laboratories – FreeStyle Libre
• B.Braun SE
• Becton Dickinson and Co.
• DarioHealth Corp.
• Dassault Systemes SE
• decide Clinical Software GmbH
• Dexcom Inc.
• F. Hoffmann La Roche Ltd.
• Glooko Inc.
• GlucoMe Ltd.
• Informed Data Systems Inc. and One Drop
• Insulet Corp.
• LifeScan IP Holdings LLC
• Medtronic Plc
• Orpyx Medical Technologies Inc.
• PHC Holdings Corp.
• Sharecare Inc.
• SOCIALDIABETES SL
• Tandem Diabetes Care Inc.
• WaveForm Technologies Inc.